PUMA
PUMA BIOTECHNOLOGY, INC.
Quick answer
PUMA is a biotech company (PBYI) headquartered in LOS ANGELES, CA, USA with 24 tracked pipeline programs.
Pipeline (24)
Neratinib
Breast Cancer
8 trials projectneratinib
HER2+ Metastatic Breast Cancer (MBC)
1 trials projectAlisertib
Small Cell Lung Cancer ( SCLC )
1 trials projectAlisertib
Hormone Receptor Positive HER-2 Negative Breast Cancer
1 trials projectAlisertib
Small Cell Lung Cancer
1 trials projectCapecitabine
Breast Cancer
1 trials projectHKI-272
Advanced Breast Cancer
2 trials projectHKI-272
Breast Cancer
1 trials projectHKI-272
Carcinoma, Non-Small-Cell Lung
1 trials projectNERATINIB
Stage IV (Metastatic) Breast Cancer
1 trials projectNeratinib
Metastatic Prostate Adenocarcinoma
1 trials projectNeratinib
Advanced Breast Cancer
1 trials projectNeratinib
Anatomic Stage I Breast Cancer
1 trials projectNeratinib
Solid Tumor, Adult
1 trials projectNeratinib
HER2-positive Breast Cancer
1 trials projectNeratinib
Metastatic Breast Cancer
1 trials projectNeratinib
Triple Negative Breast Cancer
1 trials projectNeratinib
Early-stage Breast Cancer
1 trials projectNeratinib
Early Stage HER2+ Breast Cancer
1 trials projectNeratinib
GastroEsophageal Cancer
1 trials projectNeratinib
Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
1 trials projectNeratinib
HER2 Amplified Breast Cancer
1 trials projectPaclitaxel
Breast Cancer
1 trials projectTemozolomide
Glioblastoma
1 trials